Vil01 0004 01
Viltepso Injection, Solution
Product Images NDC 73292-011
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Viltepso (NDC 73292-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ns Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vil01 0004 02
This text presents the normal dystrophin levels measured in percentage at different time points during a treatment. The baseline measurement was taken before the treatment (Week 0), and the following measurement was taken after 25 weeks of treatment. The mean dystrophin level after treatment was 0.6% G0.*
Vil01 0004 03
This is a description of a carton that contains one vial of VILTEPSO, a medication administered via intravenous infusion. The vial has a dosage of 250 mg/5 mL and is for Rx use only. The medication must be refrigerated and not frozen, and the unused portions should be discarded. It contains no preservatives and should be administered as prescribed by a healthcare provider. Contact information for the manufacturer, ONS Pharma, is included.*
Vil01 0004 04
Viltepso is an injection medication manufactured by NS Pharma, Inc. It is prescribed for intravenous infusion and contains 250mg/5mL (50mg/mL) of viltolarsen. It needs to be refrigerated at a temperature of 2°C to 8°C (36°F to 46°F). The product has the National Drug Code 73292-011-01 and the Rx-only label. The code (01) 10373292011014 does not provide any significant information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
